Jiangsu gdk Biotechnology Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 16.4 million compared to CNY 32.09 million a year ago. Revenue was CNY 16.4 million compared to CNY 32.09 million a year ago.

Net loss was CNY 17.26 million compared to CNY 23.31 million a year ago. Basic loss per share from continuing operations was CNY 0.1429 compared to CNY 0.25 a year ago. Diluted loss per share from continuing operations was CNY 0.1429 compared to CNY 0.25 a year ago.